Press Release – December 2017
G.L. Pharma becomes a Supporter of the International Aspirin Foundation
The International Aspirin Foundation is delighted to announce that G.L. Pharma GmbH has joined its group of Supporters who are aligned with The Foundation’s aims of increasing awareness and medical research in aspirin.
G.L. Pharma is a supplier to 50 markets worldwide with own marketing structures in Austria and Eastern Europe.
Specifically, they will support the Emerging Aspirin Investigator Award, which is open to junior scientists who are in the early stages of their research career, who are, or have been, contributing to the knowledge of aspirin through original independent scientific research in the field of experimental and/or clinical medicine.
Dr Christof Wachter, Head of Medical & Regulatory Affairs, commented, “We are delighted to support the International Aspirin Foundation in their work and, as a company with an interest in low dose aspirin, we are keen to encourage research into its use in both primary and secondary prevention.”
Follow this link to download a pdf copy of the press release